NovaBay Pharmaceuticals to Hold 2022 Fourth Quarter and Full Year Conference Call on March 30, 2023

Rhea-AI Summary

NovaBay Pharmaceuticals (NYSE American: NBY) plans to report its financial results for the fourth quarter and full year ended December 31, 2022 after market close on March 30, 2023. The company will also hold a conference call for investors at 4:30 p.m. ET on the same day. Participants can pre-register for the call to gain immediate access and avoid live operator delays. The call will also be available via webcast, and a replay will be accessible for two hours post-call until April 20, 2023. NovaBay specializes in developing and selling eyecare and skincare products, including its prominent product, Avenova.

Positive

• Scheduled financial results announcement for Q4 and FY 2022 offers transparency to investors.
• Conference call provides an opportunity for direct communication with management.

Negative

• None.

EMERYVILLE, Calif.--(BUSINESS WIRE)-- NovaBay^® Pharmaceuticals, Inc. (NYSE American: NBY) announces that it will report financial results for the three and 12 months ended December 31, 2022 after market close on Thursday, March 30, 2023 and will hold an investment community conference call that day beginning at 4:30 p.m. Eastern time.

Date/Time:		Thursday, March 30, 4:30 p.m. ET / 1:30 p.m. PT
Pre-Registration:		Participants can pre-register for the conference call here:
		Callers who pre-register will be given a conference passcode and unique PIN to gain immediate access to the call and bypass the live operator. Participants may pre-register at any time, including up to and after the call start time.
Dial In:		Those who choose not to pre-register can access the live conference call by dialing the following and requesting the NovaBay Pharmaceuticals call:
		866-777-2509 from within the U.S.
		412-317-5413 from outside the U.S.

The live webcast of the conference call also will be available at https://investors.novabay.com/events/. A replay of the call will be available beginning two hours after its completion through April 20, 2023 by dialing 877-344-7529 from within the U.S., 855-669-9658 from Canada or 412-317-0088 from outside the U.S., and entering conference ID 6368470. The webcast will also be archived here.

About NovaBay Pharmaceuticals, Inc:

NovaBay Pharmaceuticals, Inc. develops and sells scientifically created and clinically proven eyecare and skincare products. NovaBay’s leading product, Avenova^® Antimicrobial Lid & Lash Solution, is often prescribed by eyecare professionals for blepharitis and dry-eye disease and is also available directly to eyecare consumers through online distribution channels such as Amazon. DERMAdoctor^® offers more than 30 OTC dermatologist-developed skincare products through the DERMAdoctor website, well-known traditional and digital beauty retailers, and international distributors. NovaBay also manufactures and sells effective, yet gentle and non-irritating wound care products. The PhaseOne^® brand is distributed through commercial partners in the U.S. for professional use only, and the NeutroPhase^® brand is distributed in China by Pioneer Pharma (Hong Kong) Company Ltd.

Socialize and Stay Informed on NovaBay’s Progress
Like us on Facebook
Follow us on Twitter
Connect with NovaBay on LinkedIn
Visit NovaBay’s Website

Avenova Purchasing Information
For NovaBay Avenova purchasing information:
Please call 800-890-0329 or email sales@avenova.com
Avenova.com

DERMAdoctor Purchasing Information
For DERMAdoctor purchasing information:
Please call 877-337-6237 or email service@dermadoctor.com
DERMAdoctor.com

View source version on businesswire.com: https://www.businesswire.com/news/home/20230323005026/en/

NovaBay Contact

Justin Hall

Chief Executive Officer and General Counsel

510-899-8800

jhall@novabay.com

Investor Contact

LHA Investor Relations

Jody Cain

310-691-7100

jcain@lhai.com

Source: NovaBay Pharmaceuticals, Inc:

FAQ

When will NovaBay Pharmaceuticals report its Q4 2022 financial results?

NovaBay Pharmaceuticals will report its Q4 2022 financial results on March 30, 2023, after market close.

What time is the NovaBay Pharmaceuticals conference call?

The conference call for NovaBay Pharmaceuticals is scheduled for March 30, 2023, at 4:30 p.m. ET.

How can I listen to NovaBay Pharmaceuticals' conference call?

You can listen to the NovaBay Pharmaceuticals conference call by pre-registering or dialing in at 866-777-2509 from within the U.S. or 412-317-5413 from outside the U.S.

Is there a replay available for the NovaBay Pharmaceuticals conference call?

Yes, a replay of the NovaBay Pharmaceuticals conference call will be available starting two hours after the call until April 20, 2023.

What products does NovaBay Pharmaceuticals develop?

NovaBay Pharmaceuticals develops eyecare and skincare products, including Avenova Antimicrobial Lid & Lash Solution.